Doug A. Brooks - Concepedia

Author

Doug A. Brooks

Also Known As

Brooks, D. A., Brooks, D.A., Brooks, Doug, Brooks, Doug A., Brooks, Douglas A., D A Brooks, D BROOKS, D Brooks, D Brookss, D. A. Brooks

323

Publications

Citations

H-Index

219

Concepts

All Affiliations

University of South Australia Women's and Children's Hospital The University of Adelaide Trinity College Dublin Coombe Women & Infants University Hospital

About

Doug A. Brooks is an author at University of South Australia specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	74	3.3K
2	Natural Sciences	15	20	640
3	Engineering	6	6	301
4	Health Sciences	6	6	183
5	Education	3	3	179

Doug A. Brooks

139

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardation Patrick Tarpey, F. Lucy Raymond, Lam Son Nguyen, Nature Genetics Developmental BiologyGenetic DisorderGeneticsPsychiatric GeneticsNonsyndromic Mental Retardation	2007	284
Newborn screening for lysosomal storage disorders Peter J. Meikle, Dallas J. Grasby, Caroline Dean, Molecular Genetics and Metabolism Newborn ScreeningNeonatal GenomicsNeonatologyPediatricsDiagnosis	2006	166
Syntaxin 7 Is Localized to Late Endosome Compartments, Associates with Vamp 8, and Is Required for Late Endosome–Lysosome Fusion Barbara M. Mullock, Chez W. Smith, Gudrun Ihrke, Molecular Biology of the Cell	2000	164
Chemically Modified Oligonucleotides Exhibit Decreased Immune Stimulation in Mice Scott P. Henry, Kim Stecker, Doug A. Brooks, Journal of Pharmacology and Experimental Therapeutics	2000	146
Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy Eunice E. To, Ross Vlahos, Raymond Luong, Nature Communications	2017	146
Mutational analysis of 105 mucopolysaccharidosis type VI patients Litsa Karageorgos, Doug A. Brooks, A.C. Pollard, Human Mutation	2007	132
Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome. Allison C. Crawley, Doug A. Brooks, Vivienne Muller, Journal of Clinical Investigation	1996	131
Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. IV. A monoclonal antibody reacting specifically with a subpopulation of human B lymphocytes. Doug A. Brooks, Ian Beckman, Janette E. Bradley, The Journal of Immunology HistocompatibilityImmunocytochemical TechniqueImmunologyBlood CellPathology	1981	125
A Practical Guide to Prepare and Synthetically Modify Graphene Quantum Dots Martin J. Sweetman, Shane M. Hickey, Doug A. Brooks, Advanced Functional Materials EngineeringChemistryGraphene NanomeshesGraphene-based Nano-antennasFunctional Gqds	2019	109
Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. I. A hybridoma secreting antibody against a marker specific for human B lymphocytes. Doug A. Brooks, Ian Beckman, Janette E. Bradley, PubMed HistocompatibilityImmunologyPathologyImmunophenotypingImmunotherapy	1980	106

Page 1